Wegovy 1mg Injection contains semaglutide, a GLP-1 receptor agonist prescribed for chronic weight management in eligible adults and adolescents with obesity. As part of the recommended dose-escalation schedule, Wegovy 1mg helps reduce appetite, increase feelings of fullness, and support healthy weight loss when combined with a reduced-calorie diet and regular physical activity. The convenient once-weekly injection helps patients stay on track with their long-term weight management goals under medical supervision.

Wegovy 2.4mg Injection is a once-weekly prescription medication containing semaglutide, used alongside a reduced-calorie diet and increased physical activity to support chronic weight management in eligible adults and adolescents aged 12 years and older with obesity.